Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration.

BACKGROUND & AIMS Little is known about how endothelial cells respond to injury, regulate hepatocyte turnover and reconstitute the hepatic vasculature. We aimed to determine the effects of the vascular ectonucleotidase CD39 on sinusoidal endothelial cell responses following partial hepatectomy and to dissect purinergic and growth factor interactions in this model. METHODS Parameters of liver injury and regeneration, as well as the kinetics of hepatocellular and sinusoidal endothelial cell proliferation, were assessed following partial hepatectomy in mice that do not express CD39, that do not express ATP/UTP receptor P2Y2, and in controls. The effects of extracellular ATP on vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), and interleukin-6 responses were determined in vivo and in vitro. Phosphorylation of the endothelial VEGF receptor in response to extracellular nucleotides and growth factors was assessed in vitro. RESULTS After partial hepatectomy, expression of the vascular ectonucleotidase CD39 increased on sinusoidal endothelial cells. Targeted disruption of CD39 impaired hepatocellular regeneration, reduced angiogenesis, and increased hepatic injury, resulting in pronounced vascular endothelial apoptosis, and decreased survival. Decreased HGF release by sinusoidal endothelial cells, despite high levels of VEGF, reduced paracrine stimulation of hepatocytes. Failure of VEGF receptor-2/KDR transactivation by extracellular nucleotides on CD39-null endothelial cells was associated with P2Y2 receptor desensitization. CONCLUSIONS Regulated phosphohydrolysis of extracellular nucleotides by CD39 coordinates both hepatocyte and endothelial cell proliferation following partial hepatectomy. Lack of CD39 activity is associated with decreased hepatic regeneration and failure of vascular reconstitution.

[1]  D. Candinas,et al.  Natural killer T cell dysfunction in CD39‐null mice protects against concanavalin A–induced hepatitis , 2008, Hepatology.

[2]  S. Robson,et al.  Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. , 2007, The American journal of pathology.

[3]  W. Jochum,et al.  Platelet-Derived Serotonin Mediates Liver Regeneration , 2006, Science.

[4]  N. Fausto,et al.  Liver regeneration , 2006, Hepatology.

[5]  D. Candinas,et al.  Regenerative capacity of individual liver lobesin the microsurgical mouse model , 2006, Microsurgery.

[6]  G. Michalopoulos,et al.  Liver regeneration. , 2005, Advances in biochemical engineering/biotechnology.

[7]  R. Taub Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.

[8]  G. Weisman,et al.  The P2Y2 Nucleotide Receptor Mediates Vascular Cell Adhesion Molecule-1 Expression through Interaction with VEGF Receptor-2 (KDR/Flk-1)* , 2004, Journal of Biological Chemistry.

[9]  J. Camden,et al.  Src Homology 3 Binding Sites in the P2Y2 Nucleotide Receptor Interact with Src and Regulate Activities of Src, Proline-rich Tyrosine Kinase 2, and Growth Factor Receptors* , 2004, Journal of Biological Chemistry.

[10]  Vijaya R Arjunan,et al.  Extracellular ATP activates c‐jun N‐terminal kinase signaling and cell cycle progression in hepatocytes , 2004, Hepatology.

[11]  Kenneth J. Hillan,et al.  Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1 , 2003, Science.

[12]  Akira Takashima,et al.  CD39 is the dominant Langerhans cell–associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness , 2002, Nature Medicine.

[13]  G. Burnstock Purinergic Signaling and Vascular Cell Proliferation and Death , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[14]  ChristianGoepfert,et al.  Disordered Cellular Migration and Angiogenesis in cd39-Null Mice , 2001 .

[15]  Simon C Watkins,et al.  Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver , 2001, Hepatology.

[16]  S. Robson,et al.  CD39 Modulates Endothelial Cell Activation and Apoptosis , 2000, Molecular medicine.

[17]  K. Shitara,et al.  Properties of Two VEGF Receptors, Flt‐1 and KDR, in Signal Transduction a , 2000, Annals of the New York Academy of Sciences.

[18]  V. Cressman,et al.  Effect of Loss of P2Y2 Receptor Gene Expression on Nucleotide Regulation of Murine Epithelial Cl−Transport* , 1999, The Journal of Biological Chemistry.

[19]  W. Watt,et al.  Nucleotide-regulated Calcium Signaling in Lung Fibroblasts and Epithelial Cells from Normal and P2Y2 Receptor (−/−) Mice* , 1999, The Journal of Biological Chemistry.

[20]  Patricia D. Christie,et al.  Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation , 1999, Nature Medicine.

[21]  K. Stuhlmeier,et al.  Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis. , 1998, Biochemical and biophysical research communications.

[22]  G. Michalopoulos,et al.  Liver Regeneration , 1997, Science.

[23]  F. Bach,et al.  Identification and Characterization of CD39/Vascular ATP Diphosphohydrolase* , 1996, The Journal of Biological Chemistry.

[24]  R. Kendall,et al.  Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. , 1996, Biochemical and biophysical research communications.